No differences in the risk of hepatocellular carcinoma from using direct-acting antiviral agents or interferon in patients with chronic hepatitis C: A meta-analysis - 24/11/22

Xueying Yang ^a, 1

  These authors contributed equally to this work.

, Nan Wang ^b, 1

  These authors contributed equally to this work.

, Si Li ^b, Yanan Gu ^b, Zhen Wang ^{b, ⁎} , Dong Yang ^{c, ⁎}

^a College of Laboratory Medicine, Dalian Medical University, Dalian, China 

^b Department of Clinical Laboratory, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China 

^c Departments of Gastroenterology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China 

^⁎Corresponding authors.

Il testo completo di questo articolo è disponibile in PDF.